BioSpace News Archive

High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio

Technavio has been monitoring the global high-performance liquid chromatography market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period.

October 9, 2019
·
4 min read
Policy

THINK Surgical Receives FDA Clearance to Market Active Robot for Total Knee Replacement Procedures in the United States

Approval follows multi-center investigational clinical trial evaluating safety and efficacy of TSolution One® Total Knee Application

October 9, 2019
·
2 min read
Business and Industry Minister announces Stevenage Bioscience Catalyst as one of six new Life Science Opportunity Zones in UK

Nadhim Zahawi MP has announced that Stevenage Bioscience Catalyst (SBC) has been successful in its application to become a Life Science Opportunity Zone.

October 9, 2019
·
3 min read
Business

RSSL Wins Enlightened Employer Award

Reading Scientific Services Ltd (RSSL) secures Enlighted Employer Award in recognition of its exceptional commitment to gender equality in the workplace.

October 9, 2019
·
1 min read
Drug Development

Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia

Recruitment of 39 patients in multicenter European phase 2 trial completed ahead of schedule

October 9, 2019
·
4 min read
Business

NBE-Therapeutics Appoints Dr. Steffen Heeger as Chief Medical Officer for Leading The Clinical Development of NBE’s iADC Programs

NBE-Therapeutics AG, a biopharmaceutical company developing best-in-class, immune-stimulatory antibody drug conjugates (iADCs™), announces the appointment of Dr. Steffen Heeger as Chief Medical Officer (CMO).

October 9, 2019
·
3 min read
Cellexus go global with new distribution network

Biotech company, Cellexus International Ltd, have increased their distributor network to bring their CellMaker bioreactor range to a global market.

October 9, 2019
·
2 min read
FDA

FDA Approves Clinuvel’s Scenesse for Extreme Light Sensitivity

Scenesse is an under-the-skin implant. The drug is the company’s only approved product.

October 9, 2019
·
2 min read
·
Mark Terry
Policy

J&J Will Appeal $8 Billion Verdict of Claims Risperdal Caused Breast Growth

The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).

October 9, 2019
·
3 min read
·
Alex Keown
BioMidwest

Top 10 Life Sciences Companies with ‘Most Interesting and Meaningful’ Work

In the latest Ideal Employer Survey, BioSpace readers chimed in their thoughts on which companies across the biotech and biopharma industries were doing the most interesting and meaningful work.

October 9, 2019
·
5 min read
·
Alex Keown